Israeli telehealth startup Antidote Health, which uses AI technology to provide Americans with quality accessible healthcare, announces the closing of a $12 million Seed funding round. The investment was led by iAngels, Well-Tech Ventures, and Flint Capital, along with additional private investors.

“The convergence of two disciplines”

Antidote Health is a B2C company using artificial intelligence to provide uninsured and underinsured Americans with a virtual Health Maintenance Organization (HMO) that connects users to physicians through video calls and smart chatbots. According to the company, it chose the HMO model because of the challenging U.S. healthcare system, which has left more than 38 million Americans without proper health insurance. Many times leading the uninsured to not seek medical help when sick or wounded.